Annals of Cardiology is a peer-reviewed open-access journal dedicated to propelling the field of cardiology forward. We focus on publishing top-tier research and expert clinical perspectives to advance cardiovascular medicine. Our journal serves as a platform for sharing groundbreaking studies, clinical innovations, and educational resources in cardiovascular health. By promoting high-quality research and fostering collaboration among researchers, clinicians, and health professionals, we aim to enhance the understanding, prevention, and treatment of cardiovascular diseases worldwide.
Read MoreDespite reductions in the incidence and mortality of Cardiovascular Disease (CVD) in the last decades it still accounts over 30% of worldwide death. Although females experience higher mortality the clinical IHD guidelines do not distinguish between sexes and despite added diagnostic procedures the differences remain.
Ostial coronary lesions present significant technical challenges during Percutaneous Coronary Intervention (PCI), where imprecise stent positioning can result in geographic miss, stent protrusion, or compromised future access. Angiographic guidance alone is often limited by vessel foreshortening, overlapping structures, and variable aortic root anatomy.
Myocardial Bridging (MB) is a congenital anomaly in which a segment of an epicardial coronary artery courses intramurally through the myocardium. Although often considered benign, MB can rarely lead to Acute Coronary Syndromes (ACS) including myocardial infarction.
In Infiltrative Cardiomyopathies (IC), abnormal deposition of various substances may lead to significant cardiac weight gain. This paper examines several reports of this phenomenon, and the extent of this weight gain in various ICs.
Digoxin is a cardiac glycoside with important positive inotropic, neurohormonal, and electrophysiologic effect, which is the basis for its use in patients with heart failure and ventricular dysfunction [1].
